Mirum Pharmaceuticals, Inc. MIRM
96.96 USD -0.02 (-0.02%)
Nov 5, 2026, 10:30 AM EST
94.70 Day range 98.97
63.23 52-week range 130.00
- YTD
- +22.74%
- 1 year
- +38.33%
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 153.43 +58.2% upside
Now 96.96
- Target (low)
- 118.00
- Target (mean)
- 153.43
- Target (high)
- 200.00
Ratings (0m) 14 14 buy · 0 hold · 0 sell
- Strong buy4
- Buy10
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 14
- 1 month ago 14
- 2 months ago 14
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.44 | -0.44 – -0.44 | -0.12 | -266.7% | 195.20M | +31.1% | 1 |
| Next quarter | -0.55 | -0.55 – -0.55 | -1.09 | +49.3% | 192.21M | +20.2% | 1 |
| Current year | -15.23 | -15.23 – -15.23 | -0.47 | -3140.4% | 717.10M | +37.6% | 1 |
| Next year | -0.17 | -0.17 – -0.17 | -15.23 | +98.9% | 833.62M | +16.3% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 4, 2026 | RBC Capital | Reiterated | Outperform | Outperform |
| Nov 4, 2026 | Citizens | Maintained | Market Outperform | Market Outperform |
| Nov 4, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Nov 4, 2026 | Cantor Fitzgerald | Maintained | Overweight | Overweight |
| Oct 21, 2026 | TD Cowen | Maintained | Buy | Buy |
| Oct 15, 2026 | Stifel | Maintained | Buy | Buy |
| Oct 13, 2026 | Evercore ISI Group | Maintained | Outperform | Outperform |
| Oct 13, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Oct 12, 2026 | Citigroup | Maintained | Buy | Buy |
| Oct 12, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Oct 8, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Sep 29, 2026 | Citigroup | Maintained | Buy | Buy |
| Sep 29, 2026 | Baird | Maintained | Outperform | Outperform |
| Sep 28, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Aug 27, 2026 | Citizens | Reiterated | Market Outperform | Market Outperform |
| Aug 6, 2026 | TD Cowen | Maintained | Buy | Buy |
| Aug 6, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Aug 6, 2026 | Citizens | Maintained | Market Outperform | Market Outperform |
| Aug 6, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Jul 7, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Jul 2, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Jun 15, 2026 | Citizens | Maintained | Market Outperform | Market Outperform |
| Jun 11, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Jun 2, 2026 | Citigroup | Initiated | — | Buy |
| May 19, 2026 | Wolfe Research | Initiated | — | Outperform |
| May 7, 2026 | TD Cowen | Maintained | Buy | Buy |
| May 7, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| May 7, 2026 | Evercore ISI Group | Maintained | Outperform | Outperform |
| May 7, 2026 | Baird | Maintained | Outperform | Outperform |
| May 5, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |